Approval · Notice of Compliance 12901 · 2012
IPG-METFORMIN: Notice of Compliance 12901
Issued January 3, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12901
- Date
- January 3, 2012
- Company
- International Pharmaceutical Generics LtdOttawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Oral Antihyperglycemic Agent
- Canadian reference product
- GLUCOPHAGE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-METFORMIN | 02378043 | Approved |
| IPG-METFORMIN | 02378051 | Approved |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB